Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa

  20 March 2024

Antimicrobial resistance (AMR) is a global health threat, particularly in low- and middle-income countries (LMICs). Machine learning models, trained on whole-genome sequencing data from England, can predict AMR in E. coli, targeting key antibiotics like ciprofloxacin, ampicillin, and cefotaxime. Validation of these models using an independent dataset from Africa showed varied performance across antibiotics. The Support Vector Machine was most effective in predicting ciprofloxacin resistance, while Logistic Regression showed high accuracy for ampicillin. Key mutations associated with AMR were identified for these antibiotics.

Further reading: BMC Genomics
Author(s): Mike Nsubuga et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed